Plus inc. (NASDAQ NGS: PLUS – news) today announced that its subsidiary, OneCloud Consulting, inc., has acquired substantially all of the operating assets of Realwave, Inc. (Realwave), a software ...

NGS enables the in-depth analysis of the genome and the identification and investigation of disease-associated variants–especially when workflows include target enrichment, which focuses on specific ...

When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along with the ...

NGS Library Preparation Market to grow from USD 1.5B in 2024 to USD 4.0B by 2034 at 10% CAGR, AI integration & rising genomics research.

SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...

This study demonstrates that NGS-MSI is noninferior to IHC-MMR and can identify MSI-H tumors that IHC-MMR is unable to detect and conversely IHC-MMR can identify MMRd tumors that NGS-MSI misses. This ...

Ancient DNA studies provide critical insights into human evolution and extinct species, leveraging advanced techniques to analyze degraded genetic material.

Transaction Enhances ePlus' AI-Powered Solutions Portfolio HERNDON, Va., Sept. 10, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS - news) today announced that ...

Twist Bioscience Corporation, a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Curio Genomics, a pioneer in genomics software, today announced ...